ICOSLG anticorps (Extracellular Domain)

N° du produit ABIN108723

Cet anticorps anti-ICOSLG est un anticorps Souris Monoclonal détectant ICOSLG dans FACS et cELISA. Adapté pour Humain.

Aperçu rapide pour ICOSLG anticorps (Extracellular Domain) (ABIN108723)

Antigène: ICOSLG (Inducible T-Cell Co-Stimulator Ligand (ICOSLG))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp ICOSLG est non-conjugé

Application: Flow Cytometry (FACS), Cell-ELISA (cELISA)

Clone: GM-13C1

Détail du produit anti-ICOSLG anticorps

Épitope: Extracellular Domain

Specificité: GM13C1 recognises the extracellular domain of ICOSL transiently expressed on the cell surface of transfected BOSC cells as well as the native protein on antigen presenting cells (see reference).

Purification: Protein G

Immunogène: genetic immunisation with cDNA encoding human ICOSL (extracellular domain)

Isotype: IgG1

Information d'application

Indications d'application: Flow cytometry: 1.2 µg/10^6 cells
CELISA: 1:200 - 1:400
For each application a titration should be performed to determine the optimal concentration.

Commentaires:

Synonyms: ICOS ligand

Restrictions: For Research Use only

Stockage

Buffer: PBS, pH 7.2

Conseil sur la manipulation: Avoid repeated freezing and thawing.

Stock: 4 °C

Stockage commentaire: short term: 2 °C - 8 °C, long term: -20 °C

Détails sur ICOSLG

Antigène: ICOSLG (Inducible T-Cell Co-Stimulator Ligand (ICOSLG))

Autre désignation: ICOSL

Sujet: The inducible co-stimulator receptor (ICOS) is a member of the CD28 receptor family that is expressed on T cells. ICOS ligand (ICOSL) has been identified as a ligand that binds to ICOS, but not to CD28 or CTLA4. GM13C1 was generated by genetic immunisation and recognises the extracellular domain of ICOSL.

UniProt: O75144

Pathways: Production of Molecular Mediator of Immune Response, Activated T Cell Proliferation